Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Esperion Theraptc (ESPR)

Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Esperion Secures $150 Million Loan and $100 Million Convertible Note to Restructure Existing Convertible Debt Quiver Quantitative, Inc. - Wed Dec 18, 4:20PM CST

Esperion secures $150M term loan and $100M convertible note to repay $210M of existing convertible debt.Quiver AI SummaryEsperion has announced the completion of financing transactions aimed at reducing...

ESPR : 2.19 (+0.69%)
Esperion Strengthens Balance Sheet with Closing of Significant Refinancing Transactions GlobeNewswire - Wed Dec 18, 6:00AM CST

ESPR : 2.19 (+0.69%)
Esperion Announces $210 Million Convertible Debt Financing GlobeNewswire - Fri Dec 13, 5:00AM CST

ESPR : 2.19 (+0.69%)
Esperion Announces Licensing Agreement with Neopharm Israel for NEXLETOL® and NEXLIZET® Commercialization Quiver Quantitative, Inc. - Thu Dec 12, 5:24PM CST

Esperion licenses NEXLETOL and NEXLIZET to Neopharm Israel, receiving upfront payments and royalties from sales in the region.Quiver AI SummaryEsperion Therapeutics has announced a licensing agreement...

ESPR : 2.19 (+0.69%)
Esperion Partners with Neopharm to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Israel GlobeNewswire - Thu Dec 12, 7:00AM CST

ESPR : 2.19 (+0.69%)
ESPR Files New Drug Submissions for Nexletol & Nexlizet in Canada
ESPR Files New Drug Submissions for Nexletol & Nexlizet in Canada Zacks Investment Research - Tue Dec 3, 10:10AM CST

Esperion Therapeutics, Inc. ESPR announced that it has filed new drug submissions (NDSs) in Canada to seek approval for its once-daily, oral non-statin drugs Nexletol (bempedoic acid) and Nexlizet as a...

ESPR : 2.19 (+0.69%)
IMCR : 28.33 (-0.33%)
CSTL : 27.53 (+1.62%)
SPRO : 0.9551 (-4.30%)
Esperion Submits New Drug Applications for NEXLETOL and NEXLIZET to Health Canada to Address LDL Cholesterol and Cardiovascular Risk Quiver Quantitative, Inc. - Mon Dec 2, 5:20PM CST

Esperion submits NDSs for NEXLETOL and NEXLIZET to Health Canada, targeting LDL-C reduction and cardiovascular risk.Quiver AI SummaryEsperion has filed New Drug Submissions for its oral non-statin medications,...

ESPR : 2.19 (+0.69%)
Esperion Announces New Drug Submissions in Canada for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Treatments to Reduce LDL-C and Cardiovascular Risk GlobeNewswire - Mon Dec 2, 7:00AM CST

ESPR : 2.19 (+0.69%)
Otsuka Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia GlobeNewswire - Tue Nov 26, 7:00AM CST

ESPR : 2.19 (+0.69%)
Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference GlobeNewswire - Thu Nov 21, 7:00AM CST

ESPR : 2.19 (+0.69%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot